fucoxanthin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Inhibits EPHB2
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“The treatment of RAW264.7 cells with FX significantly reduced the phosphorylation of ERK and p38 in a concentration-dependent manner.”
Quoted verbatim from Fucoxanthin Suppresses Osteoclastogenesis via Modulation of MAP Kinase and Nrf2 Signaling.. - Study
- in vitro · not in humans
- Duration
- 4 days
- Dose
- 0, 1, 2.5 and 5 uM FX
- Population
- RAW264.7 murine macrophage cells stimulated with sRANKL or TNF-alpha/IL-6
Fucoxanthin Suppresses Osteoclastogenesis via Modulation of MAP Kinase and Nrf2 Signaling.2021PMID:33673704Permalink
Keep reading
- Everything the graph holds on fucoxanthin
- Every compound studied against EPHB2
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45EB4GQFW9FMTWRCW9TQYMH